Compounds > norethindrone

norethindrone and spironolactone

norethindrone has been researched along with spironolactone in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (41.67)	18.7374
1990's	1 (8.33)	18.2507
2000's	3 (25.00)	29.6817
2010's	3 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Ernst, B; Lill, MA; Vedani, A; Winiger, F	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Applebaum-Bowden, D; Demers, LM; Lenker, R; Wild, RA	1
Board, JA; Rosenberg, SM; Smeltzer, JS	1
Kirschner, MA; Samojlik, E; Szmal, E	1
Moore, DC	1
Buse, M; Casals-Stenzel, J; Losert, W	1
Nakamoto, M	1

Trials

1 trial(s) available for norethindrone and spironolactone

Article	Year
Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception, 1991, Volume: 44, Issue:2 Topics: Analysis of Variance; Androstane-3,17-diol; Blood Pressure; Body Weight; Cholesterol, HDL; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Norethindrone; Spironolactone; Testosterone	1991

Other Studies

11 other study(ies) available for norethindrone and spironolactone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals. Journal of medicinal chemistry, 2005, Sep-08, Volume: 48, Issue:18 Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics	2005
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Spironolactone and estrogen-progestin therapy for hirsutism. Southern medical journal, 1987, Volume: 80, Issue:4 Topics: Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Norethindrone; Spironolactone; Testosterone	1987
Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism. The Journal of clinical endocrinology and metabolism, 1987, Volume: 65, Issue:4 Topics: Adolescent; Adult; Androstane-3,17-diol; Androstanols; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Female; Hirsutism; Humans; Mestranol; Monitoring, Physiologic; Norethindrone; Prednisone; Spironolactone; Time Factors	1987
Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans. Journal of adolescent health care : official publication of the Society for Adolescent Medicine, 1987, Volume: 8, Issue:5 Topics: Acanthosis Nigricans; Adolescent; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin Resistance; Norethindrone; Spironolactone; Syndrome	1987
Progestogens with antimineralocorticoid activity. Arzneimittel-Forschung, 1985, Volume: 35, Issue:2 Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone	1985
[Clinical studies on the urinary excretion of aldosterone in myasthenia gravis]. Nihon Naibunpi Gakkai zasshi, 1967, Nov-20, Volume: 43, Issue:8 Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Aldosterone; Ambenonium Chloride; Catecholamines; Chromatography; Chromatography, Paper; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Norethindrone; Potassium; Sodium; Spectrum Analysis; Spironolactone; Triamterene	1967